Physician profile

Sophia L Fu

Surgery · West Islip, NY

NPI 1205001013

$5,965.26

in general payments reported to CMS, 2019-2025

42 companies · $631 in 2025

The $631 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).

See the full distribution for Surgery

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$2,646.10
Travel and Lodging$915.05
Entertainment$15.67

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Axogen $2,042.92 2023-2025 Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector
Carl Zeiss Meditec, INC. $1,430.51 2019-2020
Hologic Sales and Service, LLC $363.13 2023-2025 Sentimag, Magtrace, Magseed
Endomagnetics LTD $274.87 2024 Magtrace, Magseed
Daiichi Sankyo INC. $183.43 2021-2024 Vanflyta
Kub Technologies INC. $168.40 2022-2023 Mozart
Merit Medical Systems INC $159.54 2025 Savi Scout
Lilly USA, LLC $105.51 2020-2021
Gilead Sciences, INC. $82.45 2022-2024 Trodelvy
Innocoll Pharmaceuticals Limited $80.91 2023 Xaracoll
Tactile Systems Technology INC $77.58 2023-2025 Flexitouch Plus, Entre Plus, Nimbl
Stryker Corporation $73.44 2024 Spy-Phi System
Leica Microsystems INC. $67.70 2020-2025 Mammotome Revolve
Janssen Biotech, INC. $66.72 2022-2023 Erleada, Tecvayli, Darzalex
Karyopharm Therapeutics INC. $65.38 2021
Show all 42 companies
CompanyGeneral paymentsYearsTop products
Eisai INC. $52.68 2019-2022
Janssen Pharmaceuticals, INC $51.74 2022-2024 Xarelto
Stemline Therapeutics INC. $45.98 2023 Orserdu
Merck Sharp & Dohme LLC $45.46 2023-2025 Keytruda, Lynparza, Welireg
Blueprint Medicines Corporation $40.45 2021-2022
Alexion Pharmaceuticals, INC. $36.96 2021-2024 Ultomiris
Dendreon Pharmaceuticals LLC $33.44 2021
Myovant Sciences INC. $30.77 2021
Boston Scientific Corporation $30.67 2022
Beigene USA, INC. $28.08 2021
Ipsen Biopharmaceuticals, INC $25.61 2021
Genzyme Corporation $24.21 2021
Incyte Corporation $23.64 2024 Pemazyre, Monjuvi
Novartis Pharmaceuticals Corporation $22.82 2023
Ethicon US, LLC $22.61 2021
Elucent Medical $22.06 2024
Impedimed, INC. $20.62 2025
Myriad Genetic Laboratories, INC. $20.33 2023 Myrisk
Eusa Pharma (US) LLC $18.61 2022
G1 Therapeutics, INC. $17.64 2023 Cosela
Heron Therapeutics, INC. $17.61 2024 Zynrelef
Bayer Healthcare Pharmaceuticals INC. $17.60 2023
Aveo Pharmaceuticals, INC. $16.48 2022
Lifenet Health $15.24 2023
Endo Pharmaceuticals INC. $14.79 2020
Curium US LLC $13.70 2022
Takeda Pharmaceuticals U.S.A., INC. $12.97 2023 Ninlaro

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Sophia L Fu

$5,965.26

in general payments reported 2019-2025

Years
2019-2025
Top company
Axogen
Context
The $631 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).

https://glasscript.com/doctor/235125/sophia-l-fu

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.